Tyrone L. Pitt

10.2k citations

145 papers · 7.3k indexed · 2 hit papers · h-index 41

Molecular Medicine top 0.05%
Molecular Biology top 2%
Endocrinology top 0.1%
Epidemiology top 2%
Pulmonary and Respiratory Medicine top 2%

Co-authors: Mary E. Kaufmann Jane F. Turton Neil Woodford David M. Livermore Rachel Pike Hajo Grundmann Hazel M. Aucken A.L. Barth
Topics: Antibiotic Resistance in Bacteria (58 papers)Bacterial biofilms and quorum sensing (40 papers)Cystic Fibrosis Research Advances (37 papers)
Cited by: Molecular Medicine Endocrinology Applied Microbiology and Biotechnology
Journals: Journal of Clinical Investigation The Journal of Immunology PLoS ONE
Partner nations: United Kingdom Nepal United States

In The Last Decade

Tyrone L. Pitt

144 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii

2006 607 citations Neil Woodford, David M. Livermore et al. FEMS Microbiology Letters profile →
Identification of Acinetobacter baumannii by Detection of the bla _OXA-51-like Carbapenemase Gene Intrinsic to This Species

2006 537 citations Neil Woodford, Tyrone L. Pitt et al. Journal of Clinical Microbiology profile →

Peers

Countries citing papers authored by Tyrone L. Pitt

Since Specialization

Citations

This map shows the geographic impact of Tyrone L. Pitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyrone L. Pitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyrone L. Pitt more than expected).

Fields of papers citing papers by Tyrone L. Pitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tyrone L. Pitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyrone L. Pitt. The network helps show where Tyrone L. Pitt may publish in the future.

Co-authorship network of co-authors of Tyrone L. Pitt

This figure shows the co-authorship network connecting the top 25 collaborators of Tyrone L. Pitt. A scholar is included among the top collaborators of Tyrone L. Pitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tyrone L. Pitt. Tyrone L. Pitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bacterial screening of platelet components by National Health Service Blood and Transplant, an effective risk reduction measure 2017 ·Transfusion ·Carl McDonald,Jennifer Allen,Susan R. Brailsford,Anjana Roy,Joanne Ball,(unknown),(unknown),(unknown),Tyrone L. Pitt	77
2	Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands 2007 ·Journal of Cystic Fibrosis ·R.W. Brimicombe,Lenie Dijkshoorn,T. J. K. van der Reijden,(unknown),Tyrone L. Pitt,P.J. van den Broek,Harry Heijerman	26
3	Characterisation of Exiguobacterium aurantiacum isolates from blood cultures of six patients 2007 ·Clinical Microbiology and Infection ·Tyrone L. Pitt,H. Malnick,Junaid Ali Shah,Marie Anne Chattaway,(unknown),Fiona J. Cooke,Haroun N. Shah	27
4	Diagnostic multiplex PCR assay for the identification of the Liverpool, Midlands 1 and Manchester CF epidemic strains of Pseudomonas aeruginosa 2007 ·Journal of Cystic Fibrosis ·Joanne L. Fothergill,(unknown),Tyrone L. Pitt,C. Anthony Hart,Craig Winstanley	28
5	Development of extended-spectrum activity in TEM β-lactamases in hyper-mutable, mutS Escherichia coli 2006 ·Clinical Microbiology and Infection ·Matthew J. Ellington,David M. Livermore,Tyrone L. Pitt,Lucinda M. C. Hall,Neil Woodford	4
6	Development of 5′ Nuclease Real-Time PCR Assays for the Rapid Identification of the Burkholderia Mallei//Burkholderia Pseudomallei Complex 2004 ·Diagnostic Molecular Pathology ·Herbert Tomaso,Holger C. Scholz,Sascha Al Dahouk,Tyrone L. Pitt,(unknown),Heinrich Neubauer	35
7	Multilocus Sequence Typing and Evolutionary Relationships among the Causative Agents of Melioidosis and Glanders, and. 2003 ·Journal of Clinical Microbiology ·Daniela Tupy de Godoy,Gaynor Randle,Andrew J. H. Simpson,David M. Aanensen,Tyrone L. Pitt,Reimi E. Kinoshita,Brian G. Spratt	3
8	Molecular phylogeny of Burkholderia pseudomallei 2000 ·Acta Tropica ·Tyrone L. Pitt,Suwanna Trakulsomboon,David A. B. Dance	26
9	Molecular bacteriology: a diagnostic tool for the millennium 2000 ·Journal of Clinical Pathology ·Tyrone L. Pitt,(unknown)	23
10	CFTR Gene Transfer Reduces the Binding of Pseudomonas aeruginosa to Cystic Fibrosis Respiratory Epithelium 1997 ·American Journal of Respiratory Cell and Molecular Biology ·Jane C. Davies,M. Stern,A Dewar,Natasha J. Caplen,Felix M. Munkonge,Tyrone L. Pitt,F Sorgi,Leaf Huang,Andrew Bush,D M Geddes,Eric W.F.W. Alton	65
11	Immunochemical characterization of two new O serotypes ofSerratia marcescens(O27 and O28) 1996 ·FEMS Microbiology Letters ·Hazel M. Aucken,Stephen G. Wilkinson,Tyrone L. Pitt	8
12	Epidemiology of Pseudomonas aeruginosa infection in cystic fibrosis and the use of strain genotyping 1993 ·Journal of Infection ·David L. Smith,E. Grace Smith,(unknown),D E Stableforth,Líbera Maria Dalla-Costa,Tyrone L. Pitt	14
13	Homogeneity of lipopolysaccharide antigens in Pseudomonas pseudomallei 1992 ·Journal of Infection ·Tyrone L. Pitt,Hazel M. Aucken,David A. B. Dance	29
14	Serological relationships of the O antigens ofKlebsiella pneumoniaeO5,Escherichia coliO8 and a new O serotype ofSerratia marcescens 1991 ·FEMS Microbiology Letters ·Hazel M. Aucken,Tyrone L. Pitt	6
15	State of the art in typing: Klebsiella spp. 1990 ·Journal of Hospital Infection ·(unknown),Tyrone L. Pitt	24
16	Serratia marcescensinfection associated with early abortion in cows and buffaloes 1988 ·Epidemiology and Infection ·(unknown),(unknown),Tyrone L. Pitt	7
17	Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. 1987 ·Journal of Clinical Investigation ·Robert Wilson,Tyrone L. Pitt,Graham W. Taylor,David Watson,John MacDermot,David A. Sykes,David E. Roberts,Peter Cole	202
18	Monoclonal antibodies to the surface antigens ofPseudomonas aeruginosa 1986 ·FEMS Microbiology Letters ·M A Gaston,(unknown),(unknown),(unknown),Tyrone L. Pitt	9
19	Pseudomonas aeruginosa colonisation in an intensive therapy unit: role of cross infection and host factors. 1983 ·BMJ ·(unknown),Tyrone L. Pitt,Marshall Bedder,(unknown),(unknown)	40
20	Infection with netilmicin resistant Serratia marcescens in a special care baby unit. 1983 ·BMJ ·David A. Lewis,Peter M. Hawkey,(unknown),D. C. E. Speller,(unknown),(unknown),Tyrone L. Pitt	36

About Tyrone L. Pitt

Tyrone L. Pitt is a scholar working on Molecular Medicine, Endocrinology and Clinical Biochemistry, having authored 145 papers that have together received 7.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (58 papers), Bacterial biofilms and quorum sensing (40 papers) and Cystic Fibrosis Research Advances (37 papers). The work is most often cited by research in Molecular Medicine (3.7k citations), Endocrinology (1.9k citations) and Applied Microbiology and Biotechnology (312 citations). Tyrone L. Pitt has collaborated with scholars based in United Kingdom, Nepal and United States. Frequent co-authors include Mary E. Kaufmann, Jane F. Turton, Neil Woodford, David M. Livermore, Rachel Pike, Hajo Grundmann, Hazel M. Aucken, A.L. Barth, Christopher G. Dowson and Daniel E Jonas. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact